Invention Application
US20080064741A1 BIOAVAILABLE DIACYLHYDRAZINE LIGANDS FOR MODULATING THE EXPRESSION OF EXOGENOUS GENES VIA AN ECDYSONE RECEPTOR COMPLEX
有权
用于通过ECDYSONE受体复合物调节外源基因表达的生物可利用的二乙酰基配体
- Patent Title: BIOAVAILABLE DIACYLHYDRAZINE LIGANDS FOR MODULATING THE EXPRESSION OF EXOGENOUS GENES VIA AN ECDYSONE RECEPTOR COMPLEX
- Patent Title (中): 用于通过ECDYSONE受体复合物调节外源基因表达的生物可利用的二乙酰基配体
-
Application No.: US11841568Application Date: 2007-08-20
-
Publication No.: US20080064741A1Publication Date: 2008-03-13
- Inventor: Robert Hormann , David Potter , Orestes Chortyk , Colin Tice , Glenn Carlson , Andrew Meyer , Thomas Opie
- Applicant: Robert Hormann , David Potter , Orestes Chortyk , Colin Tice , Glenn Carlson , Andrew Meyer , Thomas Opie
- Main IPC: A61K31/16
- IPC: A61K31/16 ; A61K31/335 ; A61P43/00 ; C07C233/00 ; C07D311/00 ; C12N5/06 ; C12P21/04

Abstract:
The present invention relates to non-steroidal ligands for use in nuclear receptor-based inducible gene expression system, and a method to modulate exogenous gene expression in which an ecdysone receptor complex comprising: a DNA binding domain; a ligand binding domain; a transactivation domain; and a ligand is contacted with a DNA construct comprising: the exogenous gene and a response element; wherein the exogenous gene is under the control of the response element and binding of the DNA binding domain to the response element in the presence of the ligand results in activation or suppression of the gene.
Public/Granted literature
Information query